Prospects of the use of hepatic cells for extracorporeal liver support

Acta Gastro-Enterologica Belgica

Volumn 68, Issue 3, 2005, Pages 358-368

  Gerlach, Jörg C ^a,b,c,d,e  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d University of Pittsburgh   (United States)

^e MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

Author keywords

Bioreactors; Liver progenitor cells; Liver support; Primary human liver cells

Indexed keywords

ALBUMIN;

BILE SECRETION; BIOREACTOR; CONFERENCE PAPER; DIALYSIS; HEMOFILTRATION; HEPATOCYTE TRANSPLANTATION; HEPATORENAL SYNDROME; HUMAN; LIVER CELL; LIVER FAILURE; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; SURGICAL TECHNIQUE;

BIOREACTORS; EXTRACORPOREAL CIRCULATION; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION;

EID: 26944474341     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (89)

1. LUCEY M.R., BROWN K.A., EVERSON G.T., FUNG J.J., GISH R., KEEFFE E.B., KNETEMAN N.M., LAKE J.R., MARTIN P., MC DIARMID S.V., RAKELA J., SHIFFMAN M.L., SO S.K., WIESNER R.H. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl. Surg., 1997; 3: 628-637.
2. American Liver Foundation, http://www.liverfoundation.org/html/livheal. dir/livheal.htm, 2001.
3. United Network for Organ Sharing (UNOS) http://www.optn.org/latestData/, 2003.
4. CHAPMAN R.W., FORMAN D., PETO R., SMALLWOOD R. Liver transplantation for acute hepatic failure? Lancet, 1990, 335 (8680): 32-35.
5. CARACENI P., VAN THIEL D.H. Acute liver failure. Lancet, 1995, 345: 163-169.
6. SAUER I.M., KARDASSIS D., ZEILLINGER K., PASCHER A., GRUENWALD A., PLESS G., IRGANG M., KRAEMER M., PUHL G., FRANK J., MÜLLER A.R., STEINMÜLLER T., DENNER J., NEUHAUS P., GERLACH J.C. Clinical extracorporeal hybrid liver support - phase I study with primary porcine liver cells. Xenotransplantation, 2003, 10: 460-469.
7. GERLACH J., ZEILINGER K., SAUER I.M., MIEDER T., NAUMAN G., GRÜNWALD A., PLESS G., HOLAND A., MAS A., VIENKEN J., NEUHAUS P. Extracorporeal liver support : Porcine or human cell based systems ? Int. J. Artif. Org., 2002, 25 (10): 1013-1019.
8. MAZARIEGOS G.V., PATZER II J.F., LOPEZ R.C., GIRALDO M., DEVERA M.D., GROGAN T.A., ZHU Y., FULMER M.L., AMIOT B.P., KRAMER D.J. First clinical use of a novel bioartificial liver support sys-tem (BLSS). American Journal of Transplantation, 2002, 2: 260-266.
9. MAZARIEGOS G.V., KRAMER D.J., LOPEZ R.C., SHAKIL A.O., ROSENBLOOM A.J., DEVERA M.D., GIRALDO M., GROGAN T.A., ZHU Y., FULMER M.L., AMIOT B.P., PATZER II J.F. Safety observations in the Phase I clinical evaluation of the Excorp Medical BLSS after the first four patients. ASAIO Journal, 2001, 47: 471-475.
10. MORSIANI E., PAZZI P., PUVIANI A.C., BROGLI M., VALIERI L., GORINI P., SCOLETTA P., MARANGONI E., RAGAZZI R., AZZENA G., FRAZZOLI E., DI LUCA D., CASSAI E., LOMBARDI G., CAVALLARI A., FAENZA S., PASETTO A., GIRARDIS M., JOVINE E., PINNA A.D. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. International Journal of Artificial Organs, 2002, 25: 192-20.
11. WATANABE F.D., MULLON C.J., HEWITT W.R., ARKADOPOULOS N., KAHAKU E., EGUCHI S., KHALILI T., ARNAOUT W, SHACKLETON C.R., ROZGA J., SOLOMON B., DEMETRIOU A.A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Annals Surg., 1997, 225: 484-491.
12. STEVENS A.C., BUSUTTIL R., HAN S. et al. An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the HepatAssist® bioartificial liver support system for the treatment of fulmi-nant hepatic failure. Hepatology, 2001, 34 (Suppl S, Part 2): 509.
13. SUSSMAN N.L., KELLY J.H. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs, 1993, 17(1): 27-30.
14. WATANABE F.D., MULLON C.J., HEWITT W.R., ARKADOPOULOS N., KAHAKU E., EGUCHI S., KHALILI T, ARNAOUT W., SHACKLETON C.R., ROZGA J., SOLOMON B., DEMETRIOU A.A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg., 1997, 225: 484-491.
15. XU A.S.L., LUNTZ T.L., MACDONALS J.M., KUBOTA H., HSU E., LONDON R.E., REID L.M. Lineage and biology and liver. In: LANZA R.P., LANGER R., VACANTI J. (eds). Principles of Tissue Engineering chapter 41: 559-598, 2nd edition. Academic Press, San Diego CA, 1999.
16. GERLACH J.C., BOTSCH M., KARDASSIS D., LEMMENS P., SCHÖN M., JANKE J., PUHL G., UNGER J., KRAEMER M., BUSSE B., BÖHMER C., BELAL R., INGENLATH M., KOSAN M., KOSAN B., SÜLTMANN J., PATZOLD A., TIETZE S., ROISSANT R., MÜLLER C., MÖNCH E., SAUER I.M., NEUHAUS P. Experimental Evaluation of a Cell Module for Hybrid Liver Support. Int. J. An. Org., 2001, 24(11): 793-798.
17. GERLACH J., STOLL P., SCHNOY N., NEUHAUS P. Comparison of hollow fibre membranes for hepatocyte immobilisation in bioreactors. Int. J. Art. Org., 1996, 19: 610-616.
18. GERLACH J., NEUHAUS P. Culture model for primary hepatocytes. In Vitro Cell Dev. Biol., 1994, 30-A: 640-642.
19. GERLACH J., ENCKE J., HOLE O., MÜLLER C., RYAN C.J., NEUHAUS P. Bioreactor for larger scale hepatocyte in vitro perfusion. Transplantation, 1994, 58: 984-988.
20. GERLACH J., BROMBACHER J., COURTNEY J.M., NEUHAUS P. Nonenzymatic versus enzymatic hepatocyte isolation from pig livers for larger scale investigations of liver cell perfusion systems. Int. J. Art. Org., 1993, 16: 677-681.
21. GERLACH J., BROMBACHER J., KLÖPPEL K., SMITH M., SCHNOY N., NEUHAUS P. Comparison of four methods for mass hepatocyte isolation from pig and human livers. Transplantation, 1994, 57: 1318-1322.
22. GERLACH J., KLÖPPEL K., SCHÖN M.R., BROMBACHER J., COURTNEY J.M., UNGER J., NEUHAUS P. Comparison of pig hepatocyte isolation using intraoperative perfusion without warm ischemia and isolation of cells from abattoir organs after warm ischemia. Art. Org., 1993, 17: 950-953.
23. GERLACH J., BROMBACHER J., SMITH M., NEUHAUS P. High yield hepatocyte isolation from pig livers for investigation of hybrid liver support systems: Influence of collagenase concentration and body weight. J. Surg. Res., 1996, 62: 85-89.
24. GERLACH J., SCHAUWECKER H.H., KLÖPPEL K., TAUBER R., MÜLLER CH., BÜCHERL E.S. Use of hepatocytes in adhesion and Suspension cultures for liver support bioreactors. Int. J. Art. Org., 1989, 12: 788-793.
25. GERLACH J., SCHNOY N., ENCKE J., MÜLLER C., SMITH M., NEUHAUS P. Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems : electron microscopy studies. Hepatology, 1995, 22: 546-552.
26. GERLACH J., KLÖPPEL K., MÜLLER C., SCHNOY N., SMITH M., NEUHAUS P. Hepatocyte aggregate culture technique for bioreactors in hybrid liver support systems. Int. J. Art. Org., 1993, 16/12: 843-846.
27. GERLACH J., SCHNOY N., SMITH M., NEUHAUS P. Hepatocyte culture between woven capillary networks - a microscopy study. Art. Org., 1994, 18: 226-230.
28. ALLEN J.W., HASSANEIN T., BHATIA S.N. Advances in bioartificial liver devices. Hepatology, 2001, 34: 447-55.
29. SAUER I.M., KARDASSIS D., ZEILLINGER K., PASCHER A., GRUENWALD A., PLESS G., IRGANG M., KRAEMER M., PUHL G., FRANK J., MÜLLER A.R., STEINMÜLLER TH., DENNER J., NEUHAUS P., GERLACH J.C. Clinical extracorporeal hybrid liver support - phase I study with primary porcine liver cells. Xenotransplantation, 2003, 10: 460-469.
30. BAQUERIZO A., MHOYAN A., KEARNS-JONKER M., ARNAOUT W.S., SHACKLETON C., BUSUTTIL R.W., DEMETRIOU A.A., CRAMER D.V. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human Xenotransplantation. Transplantation, 1999 Jan, 15, 67 (1): 5-18.
31. PASCHER A., SAUER I.M., HAMMER C., GERLACH J.C., NEUHAUS P. Extracorporeal liver perfusion as hepatic assist in acute liver failure - a review of world experience. Xenotransplantation, 2002, 9: 309-324.
32. TSIAOUSSIS J., NEWSOME P.N., NELSON L.J., HAYES P.C., PLEVRIS J.N. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl., 2001, 7: 2-10.
33. Annual Report/Eurotransplant International Foundation.-Leiden: Annual report, 2000/Guido G. Persijn and Bernard Cohen. CIP-Gegevens Koninklijke Bibliotheek, Den HaagISBN 90-71658-19-8.
34. GERLACH J., ENCKE J., HOLE O., MÜLLER C., COURTNEY J., NEUHAUS P. Hepatocyte culture between three dimensional arranged biomatrix- coated independent artificial capillary systems and sinusoidal endothelial cell co-culture compartments. Int. J. Art. Org., 1994, 17: 301-306.
35. GERLACH J., FUCHS M., SMITH M., BORNEMANN R., NEUHAUS P., RIEDEL E. Is a clinical application of hybrid liver support systems limited by an initial disorder in cellular amino acid and a-keto acid metabolism, rather than by later gradual loss of primary hepatocyte function? Transplantation, 1996, 62: 224-228.
36. GERLACH J. Long-term liver cell cultures in bioreactors and possible application for liver support. Cell biology and Toxicology, 1997, 13: 349-355.
37. GERLACH J., ZIEMER R., NEUHAUS P. Fulminant liver failure: relevance of extracorporeal hybrid liver support systems. Int. J. Art. Org., 1996, 19: 7-13.
38. SAUER I., GERLACH J. Modular extracorporeal liver support. Art. Org., 2002, 26: 703-706.
39. SAUER I., GERLACH J. Concept of modular extracorporeal liver support for treatment of acute hepatic failure. Journal of Metabolic Brain Disease, 2002, 17 (4): 477-484.
40. GERLACH J., JÖRRES A., TROST O., HOLE O., VIENKEN J., COURTNEY J.M., GAHL G.M., NEUHAUS P. Side effects of hybrid liver support therapy: TNF-a liberation in pigs, associated with extracorporeal bioreactors. Int. J. Art. Org., 1993, 16: 604-608.
41. GERLACH J., TROST T., RYAN C.J., MEISSLER M., HOLE O., MÜLLER C., NEUHAUS P. Hybrid liver support system in a short term application on hepatectomized pigs. Int. J. An. Org., 1994, 17: 549-553.
42. GLEISNER M., BORNEMANN R., STEMEROWICZ R., MEISLER M., NEUHAUS P., GERLACH J. Immunisolation of hybrid liver support systems by semipermeable membranes. Int. J. Artif. Org., 1997, 20: 644-649.
43. JANKE J., GERLACH J., KARDASSIS D., BÖHMER C., ROSSAINT R. Effect of a hybrid liver support system on cardiopulmonary function in healty pigs. Int. J. Artif. Org., 1997, 20: 570-576.
44. GERLACH J. Development of a Hybrid Liver Support System - a review. Int. J. Art. Org., 1996, 19: 645-655.
45. BORNEMANN R., SMITH M.D., GERLACH J. Consideration of potential immunological problems in the application of xenogenic hybrid liver support. Int. J. Art. Org., 1996, 19: 655-663.
46. MUNDT A., PUHL G., MÜLLER A., SAUER I., MÜLLER C., NEUHAUS P., GERLACH J. A method to assess biochemical activity of liver cells during clinical application of extracorporeal hybrid liver support. Int. J. Art. Org., 2002, 6: 542-548.
47. SAUER I.M., KARDASSIS D., ZEILLINGER K., PASCHER A., GRUENWALD A., PLESS G., IRGANG M., KRAEMER M., PUHL G., FRANK J., MÜLLER A.R., STEINMÜLLER T., DENNER J., NEUHAUS P., GERLACH J.C. Clinical extracorporeal hybrid liver support - phase I study with primary porcine liver cells. Xenotransplantation, 2003, 10: 460-469.
48. IRGANG M., SAUER I.M., KARLAS A., ZEILINGER K., GERLACH J.C., KURTH R., NEUHAUS P., DENNER J. Porcine endogenous retroviruses (PERVs): No infection in patients treated with a bioreactor based on porcine liver cells. Clinical Virology, 2003, 28 (2): 141-154.
49. SAUER I., GERLACH J. Modular extracorporeal liver support. An. Org., 2002, 26: 703-706.
50. SAUER I.M., ZEILINGER K., PLESS G., KARDASSIS D., THERUVATH T., PASCHER A., MUELLER A.R., STEINMUELLER T., NEUHAUS P., GERLACH J.C. Extracorporeal Liver Support based on Human Liver Cells and Albumin Dialysis - Treatment of a Patient with Primary Graft Non-Function. J. of Hepatology, 2003, 39 (4): 649-653.
51. GERLACH J., ZEILINGER K., SAUER I.M., MIEDER T., NAUMAN G., GRÜNWALD A., PLESS G., HOLLAND A., MAS A., VIENKEN J., NEUHAUS P. Extracorporeal liver support : Porcine or human cell based systems? Int. J. Artif. Org., 2002, 25 (10): 1013-1019.
52. GERLACH J., KLÖPPEL K., STOLL P., VIENKEN J., MÜLLER CH., SCHAUWECKER H.H. Gas supply across membranes in bioreactors for hepatocyte culture. An. Org., 1990, 14: 328-333.
53. SAUER I.M., ZEILINGER K., OBERMAYER N., PLESS G., PASCHER A., MIEDER T., ROTH S., GOETZ M., KARDASSIS D., MAS A., NEUHAUS P., GERLACH J.C. Primary human liver cells as source for modular extracorporeal liver support - a preliminary report. Int. J. Art. Org., 2002, 25 (10): 1001-1006.
54. REYA T., MORRISON S.J., CLARKE M.F., WEISSMAN I.L. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414: 105-111.
55. RINGE J., KAPS C., BURMESTER G.R., SITTINGER M. Stem cells for regenerative medicine : Advances in the engineering of tissues and organs. Naturwissenschaften, 2002, 89: 338-351.
56. ODORICO J.S., KAUFMAN D.S., THOMSON J.A. Multilineage differentiation from human embryonic stem cell lines. Stem Cells, 2001, 19 (3): 193.
57. STROM S.C., CHOWDHURY J.R., FOX I.J. Hepatocyte transplantation for the treatment of human disease. Semin. Liver Dis., 1999, 19: 39-48.
58. STRAUER B.E., BREHM M., ZEUS T., GATTERMANN N., HERNANDEZ A., SORG R.V., KOGLER G., WERNET P. [intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. Dtsch. Med. Wochenschr., 2001, 126: 932-938.
59. KACZOROWSKI D.J., PATTERSON E.S., JASTROMB W.E., SHAMBLOTT M.J. Glucose-responsive insulin-producing cells from stem cells. Diabetes Metab. Res. Rev., 2002, 18: 442-450.
60. ISACSON O. The production and use of cells as therapeutic agents in neurodegenerative diseases. Lancet Neurol., 2003, 2: 417-424.
61. DEASY B.M., HUARD J. Gene therapy and tissue engineering based on muscle-derived stem cells. Curr. Opin. Mol. Ther., 2002, 4: 382-389.
62. SAUER I.M., KARDASSIS D., ZEILLINGER K., PASCHER A., GRUENWALD A., PLESS G., IRGANG M., KRAEMER M., PUHL G., FRANK J., MULLER A.R., STEINMULLER T., DENNER J., NEUHAUS P., GERLACH J.C. Clinical extracorporeal hybrid liver support - phase i study with primary porcine liver cells. Xenotransplantation, 2003, 10: 460-469.
63. HUMES H.D., FISSELL W.H., WEITZEL W.F. The bioartificial kidney in the treatment of acute renal failure. Kidney Int. Suppl., 2002, 61: 121-125.
64. JUNG J., ZHENG M., GOLDFARB M., ZARET K.S. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science, 1999, 284: 1998-2003.
65. ZARET K.S. Liver specification and early morphogenesis. Mech. Dev., 2000, 92: 83-88.
66. AUCHINCLOSS H., BONVENTRE J.V. Transplanting cloned cells into therapeutic promise. Nat. Biotechnol., 2002, 20 (7): 665.
67. EVARTS R.P., NAGY P., MARSDEN E., THORGEIRSSON S.S. A precursor relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis, 1987, 8: 1737-1740.
68. MITAKA T., SATTLER G.L., PUTOT H.C., MOCHIZUKI Y. Characteristics of small cell colonies developing in primary cultures of adult rat hepatocytes. Virchows Archiv B Cell Pathol., 1992, 62: 329-335.
69. MITAKA T., SATO F., MIZOGUCHI T., YOKONO T., MOCHIZUKI Y. Reconstruction of hepatic organoid by rat small hepatocytes and hepatic non-parenchymal cells. Hepatology, 1999, 29: 111-125.
70. YOON J.-H., LEE H.V.-S., LEE J.S., PARK J.B., KIM C.Y. Development of non-transformed liver cell line with differentiated-hepatocyte and urea-synthetic functions: applicable for bioartificial liver. Int. J. Artif. Organs, 1999, 18: 2127-2136.
71. KAMIYA A., KINOSHITA T., ITO Y., MATSUI T., KORIKAWA Y., SENBA E., NAKASHIMA K., TAGA T., YOSHIDA K., KISHSIMOTO T., MIYAJIMA A. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J., 1999, 18: 2127-2136.
72. KOJIMA N., KINOSHITA T., KAMIYA A., NAKARUMA K., NAKASHIMA K., TAGA T., MIYAJIMA A. Celldensity-dependent regulation of hepatic development by a gp130-independent pathway. Biocem. Biophys. Res. Commun., 2000, 277: 152-158.
73. SAKAI Y., JIANG J., KOJIMA N., KINOSHITA T., MIYAJIMA A. Enhanced in vitro maturation of fetal mouse liver cells with oncostatin M, nicotinamide and dimethylsulfoxide. Cell Transplant., 2002, 11: 435-441.
74. KINOSHITA T., SEKIGUCHI T., XU M.J., ITO Y., KAMIYA A., TSUJI K., NAKAMURA T. Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc. Natl. Sci. USA, 1999, 96: 7265-7270.
75. MIYOSHI H., EHASHI T., EMA H., HSU H.C., NAKAUCHI H., OHSHIMA N. Long-term culture of fetal liver cells using a three-dimensional porous polymer substrate. Asaio J., 2000, 46: 397-402.
76. JIANG J., KOJIMA N., KINOSHITA T., MIYAJIMA A., YAN W., SAKAI Y. Cultivation of fetal liver cells in a three-dimensional poly-1-lactic acid scaffold in the presence of oncostatin m. Cell Transplant., 2002, 11: 403-406.
77. MAC DONALD J.M., WOLFE S.P., ROY-CHOWDHURY I., KUBOTA H., REID L.M. Effect of flow configuration and membrane characteristics on membrane fouling in a novel multicoaxial hollow-fiber bioartificial liver. Ann. NY Acad. Sci., 2001, 944: 334-343.
78. SHITO M., KIM N.H., BASKARAN H., TILLES A.W., TOMPKINS R.G., YARMUSH M.L., TONER M. In vitro and in vivo evaluation of albumin synthesis rate of porcine hepatocytes in a flat-plate bioreactor. Artif. Organs., 2001, 25: 571-578.
79. STANGE J., MITZNER S.R., RISLER T., ERLEY C.M., LAUCHART W., GOEHL H., KLAMMT S., PESZYNSKI P., FREYTAG J., HICKSTEIN H., LOHR M., LIEBE S., SCHARECK W., HOPT U.T., SCHMIDT R. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif. Organs., 1999, 23: 319-330.
80. WILLINGER M., SCHIMA H., SCHMIDT C., HUBER L., VOGT G., FALKENHAGEN D., LOSERT U. Microspheres based detoxification system: in vitro study and mathematical estimation of filter performance. Int. J. Artif. Organs., 1999, 22: 573-582.
81. ASH S.R., BLAKE D.E., CARR D.J., HARKER K.D. Push-pull sorbent based pheresis for treatment of acute hepatic failure: the BioLogic-detoxifier/plasma filter System. ASAIO J., 1998, 44: 129-139.
82. KRAMER L., GENDO A., MADL C., MULLEN K.D., KAMINSKI-RUSS K., SUNDER-PLASSMANN G., SCHAFFER A., BAUER E., ROTH E., FERENCI P. A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy. Int. J. Artif. Organs., 2001, 24: 434-442.
83. GERLACH J.C. Development of a hybrid liver support system: a review. Int. J. Artif. Organs., 1996, 19: 645-654.
84. GERLACH J.C., BROMBACHER J., KLOPPEL K., SCHNOY N., NEUHAUS P. Comparison of four methods for mass hepatocyte isolation from pig and human livers. Transplantation, 1994, 57: 1318-1322.
85. GERLACH J.C., SCHNOY N., ENCKE J., SMITH M.D., MULLER C., NEUHAUS P. Improved hepatocyte in vitro maintenance in a culture model with woven multicompartment capillary systems: electron microscopy studies. Hepatology, 1995, 22: 546-552.
86. GERLACH J., TROST T., RYAN C.J., MEISSLER M., HOLE O., MULLER C., NEUHAUS P. Hybrid liver support system in a short term application on hepatectomized pigs. Int. J. Artif. Organs., 1994, 17: 549-553.
87. MITZNER S.R., STANGE J., KLAMMT S., PESZYNSKI P., SCHMIDT R., NOLDGE-SCHOMBURG G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J. Am. Soc. Nephrol., 2001, 12 Suppl.: 75-82.
88. SEIGE M., KREYMANN B., JESCHKE B., SCHWEIGART U., KOPP K.F., CLASSEN M. Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis. Transplant. Proc., 1999, 31: 1371-1375.
89. KREYMANN B., SEIGE M., SCHWEIGART U., KOPP K.F., CLASSEN M. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J. Hepatol., 1999, 31 (6): 1080-1085.